ArticleCancer biology & therapy2018

Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells.

Chao Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.